Modular Medical Stock Today
| MODD Stock | USD 0.22 -0.003 -1.36% |
Performance Weak
| Odds Of Distress Low
|
As of March 12, 2026, Modular Medical is priced at $0.21699999, reflecting a 1.36% decrease today after opening at $0.22. Current risk models assign Modular Medical a 23% probability of financial distress, reflecting a moderate probability within its capital structure. Risk-adjusted return data over the last 90 trading days classifies Modular Medical as weak in terms of performance. The performance scores are calculated from December 12, 2025 through March 12, 2026. Learn more.
IPO Date 25th of January 2007 | Asset Type Stock | Category Healthcare | Classification Health Care |
Moving together with Modular Stock
Moving against Modular Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Modular Stock Highlights
Modular Medical (MODD) is listed on NASDAQ Exchange in USA. Modular Medical is part of the Health Care Equipment & Supplies industry. The company is classified under the Health Care Equipment & Supplies sector. Modular Medical carries a micro-cap market capitalization of 30.8 M when compared with health care equipment & supplies companies. That size classification is easier to frame alongside enterprise value near 27.6 M, a workforce of about 53 people, and about 139.81 M shares outstanding. The company has 312.37 K shares sold short (1.71 days to cover). The company has return on total asset (ROA) of -149.81 % implying that it lost $149.81 for every $100 of assets on its balance sheet. This is materially lower than the sector median. Similarly, it shows a return on stockholder's equity (ROE) of -331.77 %, indicating that stockholder equity declined rather than grew. Modular Medical financial stability analysis Ownership Allocation About 82.39% of Modular Medical outstanding shares are held by general public with 2.95% owned by insiders and only 14.66% by institutions. The ownership breakdown for Modular Medical shows approximately 15% institutional, 3% insider, and 82% public. Check Modular Ownership DetailsNotable Updates
| President, Chairman | Paul DiPerna | |||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||
| Financial Strength Modular Medical (MODD) recorded a Return On Capital Employed of -119.0%, a Return On Equity of -120.0%, and a Return On Tangible Assets of -95.0%. Analysis of capital structure and cash generation suggests that Modular Medical maintains balanced financial characteristics. Current profitability metrics are under pressure, reflecting a period of reduced earnings capacity. Healthcare businesses are assessed through pipeline value, regulatory exposure, and cash burn relative to commercialization timelines.
| ||||||||||||||||
Debt LevelsModular Medical (MODD) recorded $0.67 in Net Debt To EBITDA, a Debt To Equity of 0.05x, and -$10.5 million in Net Debt. Additional disclosures note $2.0 million in Short Long Term Debt and $726 thousand in Short Long Term Debt Total, relevant to Modular Medical's position within the Health Care sector. Current AssetsModular Medical (MODD) recorded $22.6 million in Total Assets, a Return On Tangible Assets of -95.0%, and a Debt To Assets of 4.8%. Additional disclosures note $157.20 in Intangible Assets, relevant to Modular Medical's position within the Health Care sector.
| ||||||||||||||||
Earnings per Share Projection vs Actual
By analyzing Modular Medical's earnings estimates, investors can diagnose trend shifts in analyst expectations and compare EPS projections across timeframes. EPS is most informative when read together with margin stability and cash-flow conversion.
Note, estimates are forward‑looking and based on current analyst projections; they are subject to change and may differ materially from actual results. EPS TTM is historical and may not reflect future performance.
Top Institutional Holders
The institutional ownership of Modular Medical reflects the proportion of its shares held by large financial organizations, including pension funds and investment managers. Institutions holding large blocks of Modular Medical's shares can influence management strategy.| Instituion | Recorded On | Shares | |
| Perritt Capital Management Inc. | 2025-09-30 | 85 K | |
| Blair William & Co | 2025-09-30 | 67.6 K | |
| Northern Trust Corp | 2025-09-30 | 61.9 K | |
| Navigation Wealth Management, Inc. | 2025-12-31 | 55.1 K | |
| Morgan Stanley - Brokerage Accounts | 2025-09-30 | 53 K | |
| Bank Of America Corp | 2025-09-30 | 45.9 K |
Modular Medical Historical Income Statement
Recent filings indicate that Other Operating Expenses continues falling. The preceding year’s Other Operating Expenses stood at 21.91 Million. As of 03/12/2026, Total Operating Expenses is forecasted to advance to approximately 21.3 M this year, although Operating Income is expected to rise to about -16.3 M. View More FundamentalsModular Medical Against Markets
About Modular Medical Inc
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. Modular Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 25 people. A high-level view of Modular Medical emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 5.11. Modular Medical has a market cap of 30.8 M, ROE of -3.32%. 
Gabriel Shpitalnik · Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Modular Medical is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Modular (USA Stocks:MODD) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Modular Medical may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Modular Stock is Curated By:
Gabriel Shpitalnik · Member of Macroaxis Editorial BoardModular Medical Corporate Management
| Marc Goldman | Head Engineering | Profile | |
| David Bosshard | Head Operations | Profile | |
| James Besser | Chief Officer | Profile | |
| Kevin Schmid | Chief Officer | Profile |
More Resources for Modular Stock Analysis
A structured review of Modular Medical often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Modular Medical Stock in context:Modular Medical has a market cap of 30.8 M, ROE of -3.32%. Use Correlation Analysis to explore allocation context. This includes a position in Modular Medical across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy Modular Stock please use our How to Buy Modular Stock guide.Analysis related to Modular Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of Modular Medical is measured differently than book value, which reflects Modular accounting equity. Modular Medical's market capitalization is 30.8 M. With a P/B ratio of 5.11, the market values Modular Medical well above its book equity. Enterprise value stands at 27.6 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Modular Medical's intrinsic value and market price are different measures derived from different inputs. For Modular Medical, key inputs include a P/B ratio of 5.11, and ROE of -3.32%. Trading price represents the transaction level agreed by market participants.